D Goodkin

1.3k total citations
12 papers, 1.0k citations indexed

About

D Goodkin is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, D Goodkin has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Rheumatology and 3 papers in Oncology. Recurrent topics in D Goodkin's work include Multiple Sclerosis Research Studies (7 papers), Protease and Inhibitor Mechanisms (3 papers) and Polyomavirus and related diseases (3 papers). D Goodkin is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Protease and Inhibitor Mechanisms (3 papers) and Polyomavirus and related diseases (3 papers). D Goodkin collaborates with scholars based in United States, United Kingdom and Switzerland. D Goodkin's co-authors include David C. Mohr, Nicole M. Gatto, William Likosky, Emmanuelle Waubant, Richard A. Rudick, Kai Baumann, Peter Bacchetti, Lauren Gee, R. Sloan and Karen Miller and has published in prestigious journals such as The Lancet, Neurology and Journal of Neuroimmunology.

In The Last Decade

D Goodkin

12 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Goodkin United States 10 724 221 220 201 132 12 1.0k
Alexander Musallam United States 15 710 1.0× 245 1.1× 186 0.8× 117 0.6× 165 1.3× 21 1.0k
Naila Makhani United States 16 859 1.2× 264 1.2× 170 0.8× 139 0.7× 26 0.2× 30 1.2k
Damiano Paolicelli Italy 23 1.3k 1.7× 422 1.9× 433 2.0× 338 1.7× 72 0.5× 81 1.7k
Sebastian Schimrigk Germany 22 602 0.8× 248 1.1× 86 0.4× 183 0.9× 62 0.5× 42 1.1k
Stanley Hawkins United Kingdom 22 818 1.1× 214 1.0× 336 1.5× 239 1.2× 37 0.3× 64 1.4k
Cláudia Cristina Ferreira Vasconcelos Brazil 19 534 0.7× 205 0.9× 128 0.6× 143 0.7× 31 0.2× 62 966
Rana Zabad United States 16 333 0.5× 166 0.8× 75 0.3× 118 0.6× 58 0.4× 34 722
Marja‐Liisa Sumelahti Finland 16 653 0.9× 125 0.6× 145 0.7× 98 0.5× 40 0.3× 45 911
Simona Malucchi Italy 21 875 1.2× 282 1.3× 337 1.5× 376 1.9× 37 0.3× 52 1.3k
Fotini Pittas Australia 15 1.1k 1.5× 128 0.6× 167 0.8× 143 0.7× 21 0.2× 20 1.3k

Countries citing papers authored by D Goodkin

Since Specialization
Citations

This map shows the geographic impact of D Goodkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Goodkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Goodkin more than expected).

Fields of papers citing papers by D Goodkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Goodkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Goodkin. The network helps show where D Goodkin may publish in the future.

Co-authorship network of co-authors of D Goodkin

This figure shows the co-authorship network connecting the top 25 collaborators of D Goodkin. A scholar is included among the top collaborators of D Goodkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Goodkin. D Goodkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Waubant, Emmanuelle, D Goodkin, Alan Bostrom, et al.. (2003). IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology. 60(1). 52–57. 86 indexed citations
2.
Waubant, Emmanuelle, et al.. (2001). IFN-β1a May Increase Serum Levels of TIMP-1 in Patients with Relapsing-Remitting Multiple Sclerosis. Journal of Interferon & Cytokine Research. 21(3). 181–185. 26 indexed citations
3.
Waubant, Emmanuelle, Lauren Gee, Peter Bacchetti, et al.. (2001). Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. Journal of Neuroimmunology. 112(1-2). 139–145. 53 indexed citations
4.
Waubant, E., Jack Hietpas, Thomas M. Stewart, et al.. (2001). Interferon Beta-1a in Children with Multiple Sclerosis is Well Tolerated. Neuropediatrics. 32(4). 211–213. 67 indexed citations
5.
Waubant, Emmanuelle & D Goodkin. (2000). Methodological problems in evaluating efficacy of a treatment in multiple sclerosis.. PubMed. 48(2). 104–13. 2 indexed citations
6.
Mohr, David C., William Likosky, Patrick C. Dwyer, et al.. (1999). Course of Depression During the Initiation of Interferon Beta-1a Treatment for Multiple Sclerosis. Archives of Neurology. 56(10). 1263–1263. 47 indexed citations
7.
Waubant, Emmanuelle, D Goodkin, Lauren Gee, et al.. (1999). Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology. 53(7). 1397–1397. 199 indexed citations
8.
Waubant, Emmanuelle, D Goodkin, R. Sloan, & P.-B. Andersson. (1999). A pilot study of MRI activity before and during interferon beta-1a therapy. Neurology. 53(4). 874–874. 18 indexed citations
9.
Mohr, David C., D Goodkin, William Likosky, et al.. (1997). Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple Sclerosis. Archives of Neurology. 54(5). 531–533. 268 indexed citations
10.
Mohr, David C., et al.. (1996). Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-lb: Relationship to adherence to treatment. Multiple Sclerosis Journal. 2(5). 222–226. 111 indexed citations
11.
Goodkin, D. (1994). Interferon beta-1b. The Lancet. 344(8938). 1702–1703. 3 indexed citations
12.
Goodkin, D, Diane L. Cookfair, Karl Wende, et al.. (1992). Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Neurology. 42(4). 859–859. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Musallam Breakdown of academic impact, for papers by Naila Makhani Breakdown of academic impact, for papers by Damiano Paolicelli Breakdown of academic impact, for papers by Sebastian Schimrigk Breakdown of academic impact, for papers by Stanley Hawkins Breakdown of academic impact, for papers by Cláudia Cristina Ferreira Vasconcelos Breakdown of academic impact, for papers by Rana Zabad Breakdown of academic impact, for papers by Marja‐Liisa Sumelahti Breakdown of academic impact, for papers by Simona Malucchi Breakdown of academic impact, for papers by Fotini Pittas
Rankless by CCL
2026